Corinne Granger, Chair of the Board:
Corinne Granger, is Director of Research and Development, over 14 years in Cosmetics and Dermatology Industries and hold several R&D positions during more than 30 years in Health Care. She set up several R&D units around the world. She is Doctor in Medicine from Bordeaux University and hold a certificate on governance of enterprises from ESSEC business school Paris
Corinne Granger, Chair of the Board:
Muriel Atias – Permanent representative BOLD – BOLD Business Opportunities for L’Oréal Development, Observer:
Muriel Atias is the Chief Investment Officer of BOLD Business Opportunities for L’Oréal Development, L’Oréal’s corporate venture capital fund aiming to take minority stakes in innovative companies and brands with high growth potential. Having graduated from the ESSEC Business School, Muriel has over 17 years of experience in mergers and acquisitions, of which 10 in an investment bank. She joined L’Oréal in 2014, first in the Corporate Finance team in charge of acquisitions for the Group then at BOLD Business Opportunities for L’Oréal Development when launched in December 2018.
Nicolas Cordier – Permanent representative NICOCO&CO, Board member:
Nicolas Cordier is a make-up brands specialist. He worked for more than 25 years for the LVMH Group in its Beauty Division, where he held numerous international development positions for Christian Dior, in Europe and Asia where he lived for 7 years. He was then appointed Business Development Director of LVMH New Ventures (Benefit, Urban Decay) before being promoted President & CEO of MAKE UP FOR EVER, a professional make-up brand that he developed for the general public. He then worked for a US private equity firm, TSG Consumer, to develop its portfolio of make-up brands (Huda Beauty, Makeup Revolution, Zoeva). Nicolas Cordier has also created NICOCO&CO, a consulting and investment company active in beauty and consumer goods with which Global Bioenergies has concluded a consulting contract. Nicolas Cordier has just been appointed Global CEO of BYREDO, a premium fragrance, leather goods and makeup company.
Marc Delcourt, CEO and Co-founder, Board member:
Global Bioenergies, Marc Delcourt is a former student of the Ecole Normale Supérieure, biology section. After completing a thesis in North America , it is towards R & D activities in the field of bioprocess and created in 1997 the first company in the field of industrial biology, Biométhodes. He left Biométhodes in 2008, then founded Global Bioenergies.
Alain Fanet, Board member:
Alain Fanet has been an entrepreneur and executive for more than 20 years. He created two Franco-American companies in the high-tech sector: Arteris and T.sqware. He was recently Chairman and CEO of CXIgnited, an innovative company specialized in traceability of the supply channels in the luxury industry. Alain Fanet earned his PHD in Computer Science from ParisTech.
Pierre Lévi – Permanent representative of METMAN CAPITAL, Board member:
Pierre Lévi performed management functions in significant international groups, such as Groupe Salins (CEO), Faurecia (Chairman and CEO) or Rhône-Poulenc/Rhodia (Deputy President). He advises several innovative companies through his holding Metman Capital. Pierre Lévi is a graduate from Ecole des Mines of Paris and Warton School (MBA).
John Pierce – Board member:
Throughout his career, John Pierce has focused on the integration of biology with chemistry, engineering, and material sciences to create biotechnological applications in agricultural chemistry, plant genetics, and industrial biology. He received a PhD in 1980 from Michigan State University in the areas of carbohydrate chemistry and enzymology. Most recently, he was the Chief Bioscientist for BP plc after a long period with DuPont during which he led the development of a number of commercially successful biotechnological applications.